13,139 resources
Start Prev Rows 5600 - 5800 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1211 | Schizophrenia | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1212 | Seizure Disorder | active | 2024-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1213 | Seizure Disorder | active | 2025-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1214 | REM | active | 2021-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1215 | REM | active | 2021-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1216 | Benzodiazepine Withdrawal | active | 2021-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1217 | Benzodiazepine Withdrawal | active | 2025-04 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1218 | Alcohol Withdrawal | active | 2021-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1219 | Alcohol Withdrawal | active | 2025-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1220 | General Anxiety | active | 2021-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1221 | General Anxiety | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1004 | Mental Health Diagnoses | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1007 | Major Depression | active | 2017-05 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1104 | Schizophrenia or Psychotic Disorder | active | 2024-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1203 | Mental Behavioral and Neurodevelopmental Disorders | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1205 | Schizophrenia | active | 2021-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1206 | Seizure Disorder | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1207 | REM Sleep Behavior Disorder | active | 2021-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1208 | Benzodiazepine Withdrawal | active | 2021-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1209 | Alcohol Withdrawal | active | 2021-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1210 | Generalized Anxiety Disorder | active | 2021-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1050 | Potentially Harmful Gastrointestinal Antispasmodics for Older Adults | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1051 | Dipyridamole Medications | active | 2021-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1053 | Nifedipine Medications | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1054 | Potentially Harmful Antidepressants for Older Adults | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1055 | Potentially Harmful Barbiturates for Older Adults | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1057 | Meprobamate Medications | active | 2021-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1058 | Potentially Harmful Estrogens for Older Adults | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1059 | Potentially Harmful Sulfonylureas for Older Adults | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.106.11.1001 | Substance Use Disorder | active | 2025-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.106.11.1003 | Substance Use Disorder | active | 2021-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.106.11.1012 | Substance Use Disorder Treatment | active | 2021-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.106.11.1036 | Substance Use Disorder Treatment | active | 2021-02 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.106.12.1001 | Substance Use Disorder | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.106.12.1005 | Substance Use Disorder Treatment | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1060 | Desiccated Thyroid Medications | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1062 | Potentially Harmful Skeletal Muscle Relaxants for Older Adults | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1063 | Potentially Harmful Pain Medications for Older Adults | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1065 | Digoxin Medications | active | 2021-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1066 | Digoxin Medications | active | 2024-01 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1067 | Doxepin Medications | active | 2021-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1068 | Doxepin Medications | active | 2021-09 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1001 | Malignant Neoplasm of Colon | active | 2024-11 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1003 | Malignant Neoplasm of Colon | active | 2023-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1025 | Malignant Neoplasm of Lymphatic and Hematopoietic Tissue | active | 2024-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1027 | Malignant Neoplasm of Lymphatic and Hematopoietic Tissue | active | 2022-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1044 | Pap Test | active | 2017-05 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1047 | Mammography | active | 2024-11 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1051 | Colonoscopy | active | 2023-11 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1052 | Colonoscopy | active | 2017-12 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1053 | Colonoscopy | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.11.1145 | sDNA FIT Test | active | 2017-12 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1001 | Malignant Neoplasm of Colon | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1009 | Malignant Neoplasm of Lymphatic and Hematopoietic Tissue | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1017 | Pap Test | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1018 | Mammography | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1020 | Colonoscopy | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1038 | CT Colonography | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.108.12.1039 | sDNA FIT Test | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1024 | Kidney Transplant | active | 2021-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1025 | Kidney Transplant | active | 2021-02 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1026 | Dialysis Services | active | 2021-02 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1027 | Dialysis Services | active | 2021-02 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1028 | Dialysis Services | active | 2017-05 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1029 | ESRD Monthly Outpatient Services | active | 2017-08 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1052 | Kidney Transplant | active | 2017-05 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1060 | Kidney Transplant Recipient | active | 2019-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.11.1067 | Kidney Transplant | active | 2019-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.12.1012 | Kidney Transplant | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.12.1013 | Dialysis Services | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.12.1014 | ESRD Monthly Outpatient Services | active | 2017-05 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.109.12.1029 | Kidney Transplant Recipient | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1065 | DTaP Vaccine Administered | active | 2021-09 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1066 | DTaP Vaccine Administered | active | 2024-11 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1068 | Hepatitis A | active | 2019-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1070 | Hepatitis A | active | 2017-05 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1078 | Measles | active | 2021-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1080 | Measles | active | 2017-05 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1085 | Measles, Mumps and Rubella (MMR) Vaccine Administered | active | 2017-05 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1086 | Measles, Mumps and Rubella (MMR) Vaccine Administered | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1087 | Mumps | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1089 | Mumps | active | 2017-05 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1098 | Rubella | active | 2021-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.110 | Rubella | active | 2017-05 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1104 | Varicella Zoster | active | 2017-05 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1105 | Varicella Zoster | active | 2025-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1106 | Varicella Zoster Vaccine (VZV) Administered | active | 2017-05 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1107 | Varicella Zoster Vaccine (VZV) Administered | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1109 | Hepatitis A Vaccine Administered | active | 2017-05 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1110 | Hepatitis A Vaccine Administered | active | 2024-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1111 | Hepatitis B Vaccine Administered | active | 2021-09 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1112 | Hepatitis B Vaccine Administered | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1115 | Child Influenza Vaccine Administered | active | 2023-02 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1116 | Child Influenza Vaccine Administered | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1117 | Inactivated Polio Vaccine (IPV) Administered | active | 2021-09 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1118 | Inactivated Polio Vaccine (IPV) Administered | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1119 | Pneumococcal Conjugate Vaccine Administered | active | 2023-11 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1120 | Rotavirus Vaccine (3 dose schedule) Administered | active | 2017-05 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1121 | Rotavirus Vaccine (2 dose schedule) Administered | active | 2017-05 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1123 | Genital Herpes | active | 2024-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1124 | Genital Herpes | active | 2024-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1128 | Lab Tests for Sexually Transmitted Infections | active | 2022-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1129 | Chlamydia Screening | active | 2024-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1133 | Pneumococcal Conjugate Vaccine Administered | active | 2024-11 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1135 | HPV Test | active | 2024-11 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1148 | Rotavirus Vaccine (2 Dose Schedule) Administered | active | 2019-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1149 | Rotavirus Vaccine (3 Dose Schedule) Administered | active | 2019-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1150 | Advanced Illness | active | 2025-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1151 | Advanced Illness | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1152 | HiB Vaccine (3 dose schedule) | active | 2021-12 | hl7 | cvx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1153 | HiB Vaccine (3 dose schedule) Administered | active | 2021-09 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1154 | HiB Vaccine (4 dose schedule) | active | 2021-09 | hl7 | cvx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1155 | HiB Vaccine (4 dose schedule) Administered | active | 2021-09 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1156 | HiB Vaccine (3 dose schedule) Administered | active | 2024-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1157 | HiB Vaccine (4 dose schedule) Administered | active | 2024-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1158 | Competing Conditions for Respiratory Conditions | active | 2024-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.11.1159 | Competing Conditions for Respiratory Conditions | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1022 | DTaP Vaccine Administered | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1024 | Hepatitis A | active | 2017-05 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1031 | Measles, Mumps and Rubella (MMR) Vaccine Administered | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1032 | Mumps | active | 2017-05 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1037 | Rubella | active | 2017-05 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1039 | Varicella Zoster | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1040 | Varicella Zoster Vaccine (VZV) Administered | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1041 | Hepatitis A Vaccine Administered | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1042 | Hepatitis B Vaccine Administered | active | 2022-09 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1044 | Child Influenza Vaccine Administered | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1045 | Inactivated Polio Vaccine (IPV) Administered | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1046 | Pneumococcal Conjugate Vaccine Administered | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1047 | Rotavirus Vaccine (3 dose schedule) Administered | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1048 | Rotavirus Vaccine (2 dose schedule) Administered | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1049 | Genital Herpes | active | 2018-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1051 | Lab Tests for Sexually Transmitted Infections | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1052 | Chlamydia Screening | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1053 | Measles | active | 2017-05 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1059 | HPV Test | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1082 | Advanced Illness | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1083 | Hib Vaccine (3 dose schedule) | active | 2019-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1084 | Hib Vaccine (3 dose schedule) Administered | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1085 | Hib Vaccine (4 dose schedule) | active | 2019-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1086 | Hib Vaccine (4 dose schedule) Administered | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1087 | Influenza Virus LAIV Vaccine | active | 2021-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.110.12.1088 | Influenza Virus LAIV Vaccine Administered | active | 2021-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1012 | Lab Tests During Pregnancy | active | 2023-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1013 | Diagnostic Studies During Pregnancy | active | 2022-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1019 | Pregnancy Test | active | 2023-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1022 | Complications of Pregnancy, Childbirth and the Puerperium | active | 2024-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1023 | Complications of Pregnancy, Childbirth and the Puerperium | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1028 | Procedures for Sexual Activity | active | 2024-02 | hl7 | cpt | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1030 | Procedures for Sexual Activity | active | 2024-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1031 | Diagnosis for Sexual Activity | active | 2021-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1032 | Diagnosis for Sexual Activity | active | 2024-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.11.1033 | Procedures for Sexual Activity | active | 2021-02 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1007 | Lab Tests During Pregnancy | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1008 | Diagnostic Studies During Pregnancy | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1011 | Pregnancy Test | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1012 | Complications of Pregnancy, Childbirth and the Puerperium | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1016 | Congenital or Acquired Absence of Cervix | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1017 | Procedures Used to Indicate Sexual Activity | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.111.12.1018 | Diagnoses Used to Indicate Sexual Activity | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.112.11.1024 | Absence of Cervix | active | 2021-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.112.11.1025 | Absence of Cervix | active | 2021-09 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.112.11.1026 | Absence of Cervix | active | 2023-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1073 | Osteoporosis Without Current Fracture | active | 2017-12 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1074 | Osteoporosis Without Current Fracture | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1200 | Osteoporosis With Current Fracture | active | 2024-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1201 | Osteoporosis With Current Fracture | active | 2024-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1202 | DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spine | active | 2021-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1308 | Frailty Diagnosis | active | 2024-11 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1309 | Frailty Diagnosis | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1310 | Frailty Symptom | active | 2023-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.11.1311 | Frailty Symptom | active | 2023-11 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.12.1038 | Osteoporosis Without Current Fracture | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.12.1050 | Osteoporosis With Current Fracture | active | 2018-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.12.1051 | DXA (Dual energy Xray Absorptiometry) Scan | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.12.1074 | Frailty Diagnosis | active | 2019-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.113.12.1075 | Frailty Symptom | active | 2019-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.11.1021 | Narcolepsy | active | 2018-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.11.1023 | Narcolepsy | active | 2017-05 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.11.1024 | Neurologic impairment | active | 2024-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.11.1025 | Neurologic impairment | active | 2017-05 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.11.1026 | Neurologic impairment | active | 2021-09 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.12.1011 | Narcolepsy | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.114.12.1012 | Neurologic impairment | active | 2024-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1149 | Substance Use Disorder Long Acting Medication | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.115.11.1248 | Retinal or Dilated Eye Exam | active | 2025-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.115.12.1088 | Retinal or Dilated Eye Exam | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1150 | Substance Use Disorder Short Acting Medication | active | 2024-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1151 | Substance Use Disorder Long Acting Medication Administration | active | 2025-01 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1152 | Substance Use Disorder Short Acting Medication Administration | active | 2024-02 | hl7 | cms | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1155 | Substance Use Disorder Short Acting Medication Administration | active | 2023-11 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1156 | Substance Use Disorder Long Acting Medication Administration | active | 2021-11 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1157 | Substance Use Disorder Short Acting Medication Administration | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1163 | Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine | active | 2022-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1164 | Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine | active | 2022-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1165 | Hospice Diagnosis | active | 2022-08 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1166 | Hospice Diagnosis | active | 2022-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1167 | Palliative Care Diagnosis | active | 2022-08 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1168 | Palliative Care Diagnosis | active | 2022-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1169 | Palliative Care Diagnosis | active | 2022-08 | hl7 | icd |
FHIR